NeoGenomics NEO
$14.82 −$0.27 (-1.79%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $14.79 -0.20%
Open$14.86
Prev close$15.09
Day range$14.63 – $15.14
Volume1.18M
Market cap$1.92B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$209.25M+11.4% YoY
Operating profit-$7.94M+60.2% YoY
Net profit-$7.55M+72.2% YoY
Diluted EPS-$0.06+71.4% YoY
Free cash flow-$20.66M-3,724.2% YoY
Operating cash flow-$8.89M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin44.8%
Operating margin-6.2%
Net margin-4.1%
Return on equity-3.9%
Return on assets-2.3%
Return on invested capital-2.7%
Current ratio3.53
Liabilities / assets41.9%
Cash & investments$139.28M
Total debt$443.14M
Net cash (debt)-$303.86M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $209.25M | $201.66M | $186.67M | $727.33M | $190.17M |
| Total Operating Revenue | $209.25M | $201.66M | $186.67M | $727.33M | $190.17M |
| Cost of Revenue | $112.67M | $109.78M | $105.81M | $413.04M | $106.83M |
| Gross Profit | $96.59M | $91.88M | $80.86M | $314.29M | $83.34M |
| Operating Expense | $104.53M | $101.65M | $99.11M | $402.42M | $96.13M |
| Selling and Admin Expenses | $94.67M | $90.89M | $89.57M | $331.65M | $53.26M |
| -Selling & Marketing Expense | $27.60M | $27.28M | $23.83M | $91.92M | $23.35M |
| -General & Admin Expense | $67.07M | $63.61M | $65.74M | $239.74M | $29.91M |
| Research & Development | $9.86M | $10.76M | $9.53M | $37.08M | $9.18M |
| Operating Profit | -$7.94M | -$9.77M | -$18.24M | -$88.13M | -$12.79M |
| Net Non-Operating Interest Income (Expense) | -$71,000.00 | $433,000.00 | $675,000.00 | $5.32M | $924,000.00 |
| Non-Operating Interest Income | $1.20M | $1.21M | $1.27M | $9.07M | $1.52M |
| Non-Operating Interest Expense | $1.27M | $781,000.00 | $598,000.00 | $3.75M | $599,000.00 |
| Other Income (Expense) | -$9,000.00 | $11.16M | -$12,000.00 | -$27.46M | -$542,000.00 |
| Special Income (Charges) | $0.00 | $11.18M | – | -$27.75M | -$626,000.00 |
| -Less:Impairment of Capital Assets | $0.00 | $0.00 | – | $27.75M | $626,000.00 |
| Other Non-Operating Income (Expenses) | -$9,000.00 | -$17,000.00 | -$12,000.00 | $296,000.00 | $84,000.00 |
| Pretax Profit | -$8.02M | $1.83M | -$17.58M | -$110.27M | -$12.41M |
| Tax | -$475,000.00 | -$412,000.00 | -$472,000.00 | -$2.24M | -$2.53M |
| Net Profit | -$7.55M | $2.24M | -$17.11M | -$108.03M | -$9.88M |
| Profit from Continuing Operations | -$7.55M | $2.24M | -$17.11M | -$108.03M | -$9.88M |
| Net Income to Parent Company | -$7.55M | $2.24M | -$17.11M | -$108.03M | -$9.88M |
| Net Income to Common Stockholders | -$7.55M | $2.24M | -$17.11M | -$108.03M | -$9.88M |
| Basic EPS | -$0.06 | $0.02 | -$0.13 | -$0.84 | -$0.08 |
| Diluted EPS | -$0.06 | $0.02 | -$0.13 | -$0.84 | -$0.08 |
| -Less:Other Special Charges | – | -$11.18M | – | – | – |
| Depreciation & Amortization & Depletion | – | – | – | $33.69M | – |
| -Depreciation & Amortization | – | – | – | $33.69M | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.38B | $1.35B | $1.35B | $1.36B | $1.36B |
| Total Current Assets | $410.08M | $381.48M | $373.68M | $376.29M | $376.29M |
| Cash and Cash Equivalents & Short-Term Investments | $139.28M | $145.54M | $146.14M | $159.62M | $159.62M |
| -Cash and Cash Equivalents | $139.28M | $145.54M | $146.14M | $159.62M | $159.62M |
| Receivables | $213.41M | $175.41M | $167.42M | $159.24M | $159.24M |
| -Accounts Receivable | $213.41M | $175.41M | $167.42M | $159.24M | $159.24M |
| Prepaid Assets | $22.77M | $23.59M | $23.67M | $21.44M | $21.44M |
| Inventory | $25.50M | $27.14M | $29.84M | $28.57M | $28.57M |
| Other Current Assets | $9.12M | $9.81M | $6.61M | $7.42M | $7.42M |
| Total Non-Current Assets | $966.83M | $970.77M | $972.85M | $983.54M | $983.54M |
| Net PPE | $170.21M | $166.20M | $160.36M | $163.28M | $163.28M |
| -Gross PPE | $400.78M | $389.68M | $376.33M | $372.34M | $372.34M |
| -Accumulated Depreciation | -$230.57M | -$223.48M | -$215.97M | -$209.06M | -$209.06M |
| Goodwill and Other Intangible Assets | $787.62M | $795.26M | $802.89M | $810.87M | $810.87M |
| -Goodwill | $524.00M | $524.00M | $524.00M | $524.34M | $524.34M |
| -Other Intangible Assets | $263.63M | $271.26M | $278.90M | $286.53M | $286.53M |
| Other Non-Current Assets | $9.00M | $9.31M | $9.60M | $9.39M | $9.39M |
| Total Liabilities | $576.28M | $566.51M | $517.77M | $523.27M | $523.27M |
| Total Current Liabilities | $116.17M | $105.88M | $84.59M | $88.30M | $88.30M |
| Payables | $32.93M | $20.95M | $25.90M | $23.09M | $23.09M |
| -Accounts Payable | $32.93M | $20.95M | $25.90M | $23.09M | $23.09M |
| Current Accrued Expenses | $16.51M | $23.05M | $12.73M | $12.00M | $12.00M |
| Short-Term Debt and Capital Lease Obligation | $6.00M | $5.43M | $4.83M | $4.78M | $4.78M |
| -Current Capital Lease Obligation | $6.00M | $5.43M | $4.83M | $4.78M | $4.78M |
| Current Deferred Liabilities | $267,000.00 | $194,000.00 | $561,000.00 | $851,000.00 | $851,000.00 |
| Total Non-Current Liabilities | $460.11M | $460.63M | $433.18M | $434.97M | $434.97M |
| Long Term Debt and Capital Lease Obligation | $443.14M | $442.94M | $403.70M | $404.68M | $404.68M |
| -Long Term Debt | $374.69M | $374.24M | $342.24M | $341.86M | $341.86M |
| -Long Term Capital Lease Obligation | $68.45M | $68.70M | $61.46M | $62.82M | $62.82M |
| Non-Current Deferred Liabilities | $16.10M | $16.82M | $17.45M | $18.22M | $18.22M |
| Other Non-Current Liabilities | $867,000.00 | $862,000.00 | $12.03M | $12.07M | $12.07M |
| Total Equity | $800.64M | $785.73M | $828.76M | $836.56M | $836.56M |
| Stockholders' Equity | $800.64M | $785.73M | $828.76M | $836.56M | $836.56M |
| Capital Stock | $131,000.00 | $130,000.00 | $129,000.00 | $129,000.00 | $129,000.00 |
| -Common Stock | $131,000.00 | $130,000.00 | $129,000.00 | $129,000.00 | $129,000.00 |
| Additional Paid-In Capital | $1.28B | $1.26B | $1.28B | $1.27B | $1.27B |
| Retained Earnings | -$456.22M | -$448.67M | -$450.91M | -$433.81M | -$433.81M |
| Less: Treasury Stock | -$25.00M | -$25.00M | – | – | – |
| Gains/Losses Not Affecting Retained Earnings | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 |
| -Short Term Investments | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$8.89M | $19.96M | -$8.14M | $5.23M | $1.34M |
| Net cash flow from continuing operations | -$8.89M | $19.96M | -$8.14M | $5.23M | $1.34M |
| Net Income from Continuing Operations | -$7.55M | $2.24M | -$17.11M | -$108.03M | -$9.88M |
| Gain/Loss from Continuing Operations | $0.00 | – | – | $31,000.00 | – |
| Depreciation & Depletion & Amortization | $16.19M | $16.21M | $16.41M | $67.82M | $16.40M |
| Other Non-Cash Items | $2.31M | $2.18M | $2.12M | $8.43M | $1.77M |
| Change in Working Capital | -$28.68M | $2.29M | -$19.20M | -$32.10M | -$15.64M |
| -Change in Receivables | -$38.01M | -$7.98M | -$8.18M | -$6.18M | -$4.21M |
| -Change in Inventory | $1.64M | $2.70M | -$1.27M | -$1.54M | -$28,000.00 |
| -Change in Prepaid Assets | $621,000.00 | -$1.46M | -$1.40M | $1.56M | $3.21M |
| -Change in Payables and Accrued Expense | $8.31M | $10.89M | -$6.29M | -$20.36M | -$10.68M |
| -Change in Other Current Liabilities | -$508,000.00 | -$1.23M | -$1.30M | -$2.22M | -$1.23M |
| -Change In Other Working Capital | -$727,000.00 | -$626,000.00 | -$769,000.00 | -$3.36M | -$2.69M |
| Net cash flow from investing | -$11.85M | -$8.32M | -$5.00M | -$12.34M | -$6.31M |
| Net Cash Flow from Continuing Investing Activities | -$11.85M | -$8.32M | -$5.00M | -$12.34M | -$6.31M |
| Net PPE Purchase and Sale | -$11.77M | -$8.22M | -$5.00M | -$27.01M | -$7.87M |
| Net Business Purchase and Sale | $0.00 | – | – | -$6.45M | $0.00 |
| Net Investment Purchase and Sale | $0.00 | $0.00 | $0.00 | $19.56M | $0.00 |
| Net Other Investing Changes | -$75,000.00 | – | – | $1.57M | – |
| Financing Cash Flow | $14.48M | -$12.24M | -$338,000.00 | -$200.29M | $431,000.00 |
| Net Cash Flow from Continuing Financing Activities | $14.48M | -$12.24M | -$338,000.00 | -$200.29M | $431,000.00 |
| Net Issuance Payments Of Debt | $860,000.00 | – | – | -$201.25M | $0.00 |
| Net Common Stock Issuance | $42.04M | -$24.66M | -$338,000.00 | $962,000.00 | -$2.21M |
| Net Other Financing Charges | -$404,000.00 | – | – | – | – |
| Ending Cash Balance | $139.28M | $145.54M | $146.14M | $159.62M | $159.62M |
| Net Change in Cash | -$6.26M | -$604,000.00 | -$13.48M | -$207.39M | -$4.53M |
| Beginning Cash Balance | $145.54M | $146.14M | $159.62M | $367.01M | $164.12M |
| Free Cash Flow | -$20.66M | $11.74M | -$13.14M | -$21.78M | -$6.53M |
No comments yet — be the first to weigh in on NEO.
Sign in to join the discussion.